CAROLYN RHODES: Open Payments
NPI 1194230490 · NEWARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 50 payments from 13 companies in 2025. Trend: 2023 $842 · 2024 $939 · 2025 $1,171
Food & beverage: $1,071Education: $100
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $290 |
| Astellas Pharma US Inc | 6 | $208 |
| Telix Pharmaceuticals | 7 | $134 |
| Myriad Genetic Laboratories, Inc. | 4 | $89 |
| Ferring Pharmaceuticals Inc. | 4 | $74 |
| TOLMAR, INC. | 3 | $66 |
| ABBVIE INC. | 3 | $64 |
| Antares Pharma, Inc. | 2 | $53 |
| IMMUNITYBIO, INC. | 2 | $48 |
| Teleflex LLC | 1 | $46 |
Products named: GEMTESA, ILLUCCIX, Xtandi, PROLARIS, ADSTILADRIN, ORGOVYX, XYOSTED, ANKTIVA.
Industry payments across NY — which companies pay providers there.
